AGP Picks
View all

Aruba Health Monitor
Provided by AGP

Aruba Health Monitor: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Aruba Health Monitor.

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

Press releases published on June 29, 2026

Helus Pharma Reports Recent Business Highlights and Fiscal Year 2026 Financial Results
32 minutes ago

Helus Pharma Reports Recent Business Highlights and Fiscal Year 2026 Financial Results

Indeterminate GlobeNewswire
BrainsWay Presents Positive Data from Largest Real-World Study of Deep TMS™ in Patients with Comorbid PTSD and Major Depressive Disorder
42 minutes ago

BrainsWay Presents Positive Data from Largest Real-World Study of Deep TMS™ in Patients with Comorbid PTSD and Major Depressive Disorder

Indeterminate GlobeNewswire
Kailera Therapeutics Appoints Kathleen Tregoning as Chief Corporate Affairs Officer
42 minutes ago

Kailera Therapeutics Appoints Kathleen Tregoning as Chief Corporate Affairs Officer

Indeterminate GlobeNewswire
Xilio Therapeutics Appoints Ben Harshbarger as Chief Legal Officer
42 minutes ago

Xilio Therapeutics Appoints Ben Harshbarger as Chief Legal Officer

Indeterminate GlobeNewswire
Palvella Therapeutics Submits First Module of Rolling New Drug Application to FDA for QTORIN™ Rapamycin for the Treatment of Microcystic Lymphatic Malformations
42 minutes ago

Palvella Therapeutics Submits First Module of Rolling New Drug Application to FDA for QTORIN™ Rapamycin for the Treatment of Microcystic Lymphatic Malformations

Indeterminate GlobeNewswire
Tonix Pharmaceuticals Announces First Patient Enrolled in Phase 2 HORIZON Study of TNX-102 SL for the Treatment of Major Depressive Disorder (MDD)
an hour ago

Tonix Pharmaceuticals Announces First Patient Enrolled in Phase 2 HORIZON Study of TNX-102 SL for the Treatment of Major Depressive Disorder (MDD)

Indeterminate GlobeNewswire
Dyadic Expands IP Protection and Business Development Activities in Japan
an hour ago

Dyadic Expands IP Protection and Business Development Activities in Japan

Indeterminate GlobeNewswire
George Medicines appoints Brendan Walsh as Senior Vice President of Supply Chain & Technical Operations
an hour ago

George Medicines appoints Brendan Walsh as Senior Vice President of Supply Chain & Technical Operations

Indeterminate GlobeNewswire
Dr. Mariusz Sapijaszko elected President of the Canadian Dermatology Association
an hour ago

Dr. Mariusz Sapijaszko elected President of the Canadian Dermatology Association

Indeterminate GlobeNewswire
Le Dr Mariusz Sapijaszko élu président de l’Association canadienne de dermatologie
an hour ago

Le Dr Mariusz Sapijaszko élu président de l’Association canadienne de dermatologie

Indeterminate GlobeNewswire
Relmada Therapeutics Joins Russell 2000® and Russell 3000® Indexes
an hour ago

Relmada Therapeutics Joins Russell 2000® and Russell 3000® Indexes

Indeterminate GlobeNewswire
Sagimet Biosciences Joins the Russell 2000® and Russell 3000® Indexes
an hour ago

Sagimet Biosciences Joins the Russell 2000® and Russell 3000® Indexes

Indeterminate GlobeNewswire
Agios to Host Second Quarter 2026 Financial Results Conference Call and Webcast on July 30 at 8:00 a.m. ET
an hour ago

Agios to Host Second Quarter 2026 Financial Results Conference Call and Webcast on July 30 at 8:00 a.m. ET

Indeterminate GlobeNewswire
Satellos Receives FDA Fast Track Designation for SAT-3247 for the Treatment of Duchenne Muscular Dystrophy
an hour ago

Satellos Receives FDA Fast Track Designation for SAT-3247 for the Treatment of Duchenne Muscular Dystrophy

Indeterminate GlobeNewswire
Dianthus Therapeutics Announces Initiation of Phase 3 Emerge Trial of Claseprubart in Generalized Myasthenia Gravis
an hour ago

Dianthus Therapeutics Announces Initiation of Phase 3 Emerge Trial of Claseprubart in Generalized Myasthenia Gravis

Indeterminate GlobeNewswire
NetraMark Signs New NetraAI Clinical Trial Analysis Agreement with Late-Stage Biopharmaceutical Company
an hour ago

NetraMark Signs New NetraAI Clinical Trial Analysis Agreement with Late-Stage Biopharmaceutical Company

Indeterminate GlobeNewswire
BioCryst Sharpens Scientific Focus on External Innovation with Wind Down of Internal Discovery Programs and Closure of Birmingham Research Facility
an hour ago

BioCryst Sharpens Scientific Focus on External Innovation with Wind Down of Internal Discovery Programs and Closure of Birmingham Research Facility

Indeterminate GlobeNewswire
Conavi Medical Receives $1.25 Million Milestone Payment Under Ontario Life Sciences Scale-Up Fund
an hour ago

Conavi Medical Receives $1.25 Million Milestone Payment Under Ontario Life Sciences Scale-Up Fund

Indeterminate GlobeNewswire
NovaBridge Biosciences Appoints Dr. Srishti Gupta as Chief Executive Officer
an hour ago

NovaBridge Biosciences Appoints Dr. Srishti Gupta as Chief Executive Officer

Indeterminate GlobeNewswire
Biogen to Highlight Breadth of Alzheimer’s Disease Portfolio at AAIC 2026, Including Phase 2 CELIA Data for Diranersen
an hour ago

Biogen to Highlight Breadth of Alzheimer’s Disease Portfolio at AAIC 2026, Including Phase 2 CELIA Data for Diranersen

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Aruba Health Monitor

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.